Clinical Trials Browser

Phase 2 × Recurrence × tagraxofusp × Clear all

NCT04342962 2025-01-30

Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia

Phase 2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute